Differential sensitivity to Arg side chain modification of IL-1 beta binding to type I and type II receptors
The central role of interleukin-1 (IL-1) in several disease processes, including fever and inflammation, makes the characterization of ligand-receptor interaction of prime importance. The role of arginine (Arg) side chains of hr-IL-1 beta in receptor recognition was studied by the modification of Ar...
Saved in:
Published in: | Agents and Actions Vol. 41; no. 1-2; pp. 105 - 107 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
01-03-1994
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The central role of interleukin-1 (IL-1) in several disease processes, including fever and inflammation, makes the characterization of ligand-receptor interaction of prime importance. The role of arginine (Arg) side chains of hr-IL-1 beta in receptor recognition was studied by the modification of Arg residues with the specific reagent 1,2-cyclohexanedione. It was found that chemical modification of Arg residues decreased the binding potential of IL-1 beta to type I receptor dramatically (by 230-fold) while the affinity to type II receptor was reduced only moderately (by 10-fold), with an insignificant reduction of the dissociation rate. These studies suggest that intact Arg side chains of IL-1 beta may be necessary for high affinity binding to type I IL-1 receptor, but have less importance for the interaction of IL-1 beta with type II IL-1 receptor. This observation may be useful in the study of type II IL-1 receptor-mediated biological responses and design of receptor-subtype specific ligands as well. |
---|---|
AbstractList | The central role of interleukin-1 (IL-1) in several disease processes, including fever and inflammation, makes the characterization of ligand-receptor interaction of prime importance. The role of arginine (Arg) side chains of hr-IL-1 beta in receptor recognition was studied by the modification of Arg residues with the specific reagent 1,2-cyclohexanedione. It was found that chemical modification of Arg residues decreased the binding potential of IL-1 beta to type I receptor dramatically (by 230-fold) while the affinity to type II receptor was reduced only moderately (by 10-fold), with an insignificant reduction of the dissociation rate. These studies suggest that intact Arg side chains of IL-1 beta may be necessary for high affinity binding to type I IL-1 receptor, but have less importance for the interaction of IL-1 beta with type II IL-1 receptor. This observation may be useful in the study of type II IL-1 receptor-mediated biological responses and design of receptor-subtype specific ligands as well. |
Author | Arányi, P Koncz, S Tömösközi, Z Bugovics, G |
Author_xml | – sequence: 1 givenname: Z surname: Tömösközi fullname: Tömösközi, Z organization: Institute for Drug Research, Budapest, Hungary – sequence: 2 givenname: G surname: Bugovics fullname: Bugovics, G – sequence: 3 givenname: S surname: Koncz fullname: Koncz, S – sequence: 4 givenname: P surname: Arányi fullname: Arányi, P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8079812$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkEtLAzEUhYNUalvduBeyFkZvHjOTLGu1OlBwo-BuyORRI21mSKLQf29Li67ugfuds_imaBT6YBG6JnBHAOr7hyUQKSoO9RmaEE6hkCA-RmgCUJUFp1JeoGlKXwBlSQQZo7GAWgpCJ2jz6J2z0Ybs1QYnG5LP_sfnHc49nsc1Tt5YrD-VD3jbG--8Vtn3AfcON6uC4M5mhTsfjA_rQyfvBosbrII5xQZHq-2Q-5gu0blTm2SvTneG3pdPb4uXYvX63Czmq0JTTnLBXNlRLqmpqHKmdoI5Xruqc67kSjKmbQXMEGkYUcpoQwmBipVcdPsXOMVm6Pa4q2OfUrSuHaLfqrhrCbQHY-2_sT18c4SH725rzR96UsR-AZpVZ_8 |
Cites_doi | 10.1016/0167-4838(91)90437-5 10.1093/clinids/6.1.51 10.1016/0014-5793(87)80307-1 10.1111/j.1432-1033.1986.tb10066.x 10.1016/S0021-9258(19)41933-9 10.1016/S0021-9258(19)39265-8 10.1016/0008-8749(81)90034-4 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION |
DOI | 10.1007/BF01986407 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1420-908X |
EndPage | 107 |
ExternalDocumentID | 10_1007_BF01986407 8079812 |
Genre | Journal Article |
GroupedDBID | .55 .GJ 23M 28- 29~ 40D 40E 41~ 53G 5GY 5QI 5RE 95- 95. 95~ ACGFS AEFIE ALMA_UNASSIGNED_HOLDINGS AMKLP ASPBG AVWKF AZFZN BBWZM CGR CS3 CUY CVF ECM EIF F5P KOW M4Y N2Q NPM NU0 QOK R4E RHV ROL SBY SDE SDH SOJ TSV WH7 WK6 X7M ZGI ZXP ~EX AAYXX CITATION |
ID | FETCH-LOGICAL-c241t-3f5b2492d62afd7f83f47f6bff54a933ce603d19d31aadcd211063548b3ce0fa3 |
ISSN | 0065-4299 |
IngestDate | Fri Aug 23 02:00:41 EDT 2024 Fri Feb 23 03:46:02 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1-2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c241t-3f5b2492d62afd7f83f47f6bff54a933ce603d19d31aadcd211063548b3ce0fa3 |
PMID | 8079812 |
PageCount | 3 |
ParticipantIDs | crossref_primary_10_1007_BF01986407 pubmed_primary_8079812 |
PublicationCentury | 1900 |
PublicationDate | 1994-Mar 1994-3-00 |
PublicationDateYYYYMMDD | 1994-03-01 |
PublicationDate_xml | – month: 03 year: 1994 text: 1994-Mar |
PublicationDecade | 1990 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Agents and Actions |
PublicationTitleAlternate | Agents Actions |
PublicationYear | 1994 |
References | V. B. Nanduri (BF01986407_CR2) 1991; 1118 P. Wingfield (BF01986407_CR7) 1986; 160 C. A. Dinarello (BF01986407_CR1) 1984; 6 L. Patthy (BF01986407_CR5) 1975; 250 BF01986407_CR6 J. J. Huang (BF01986407_CR3) 1987; 223 L. J. Rosenwasser (BF01986407_CR8) 1981; 63 D. Boraschi (BF01986407_CR9) 1992 L. Gehrke (BF01986407_CR4) 1990; 265 |
References_xml | – volume: 1118 start-page: 25 year: 1991 ident: BF01986407_CR2 publication-title: Biochem. Biophys. Acta doi: 10.1016/0167-4838(91)90437-5 contributor: fullname: V. B. Nanduri – volume: 6 start-page: 51 year: 1984 ident: BF01986407_CR1 publication-title: Rev. Infect. Dis. doi: 10.1093/clinids/6.1.51 contributor: fullname: C. A. Dinarello – start-page: 19 volume-title: Neuroimmunology of Fever year: 1992 ident: BF01986407_CR9 contributor: fullname: D. Boraschi – volume: 223 start-page: 294 year: 1987 ident: BF01986407_CR3 publication-title: FEBS Lett. doi: 10.1016/0014-5793(87)80307-1 contributor: fullname: J. J. Huang – volume: 160 start-page: 491 year: 1986 ident: BF01986407_CR7 publication-title: Eur. J. Biochem. doi: 10.1111/j.1432-1033.1986.tb10066.x contributor: fullname: P. Wingfield – volume: 250 start-page: 557 year: 1975 ident: BF01986407_CR5 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)41933-9 contributor: fullname: L. Patthy – volume: 265 start-page: 5922 year: 1990 ident: BF01986407_CR4 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)39265-8 contributor: fullname: L. Gehrke – ident: BF01986407_CR6 – volume: 63 start-page: 134 year: 1981 ident: BF01986407_CR8 publication-title: Cell. Immunol. doi: 10.1016/0008-8749(81)90034-4 contributor: fullname: L. J. Rosenwasser |
SSID | ssj0055181 ssj0008282 |
Score | 1.3626786 |
Snippet | The central role of interleukin-1 (IL-1) in several disease processes, including fever and inflammation, makes the characterization of ligand-receptor... |
SourceID | crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 105 |
SubjectTerms | Arginine - chemistry Arginine - metabolism Binding Sites Cloning, Molecular Humans Interleukin-1 - chemistry Interleukin-1 - metabolism Macrophages - metabolism Radioligand Assay Receptors, Interleukin-1 - metabolism Recombinant Proteins - metabolism |
Title | Differential sensitivity to Arg side chain modification of IL-1 beta binding to type I and type II receptors |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8079812 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZp-7KXsW4r6y5F0LUvqYsVy7dHN0lXswuBZtDupdiyFcKYXZpkkP6s_ZD9pp0jybKzvnQPe7GNIgmi83FuOhdC3otYYOhk5ri54A5nA-HEYGg5oSeFx4JcCOXvuLgMv1xFozEf93pN66d27L9SGsaA1pg5-w_UtpvCAHwDzeEJVIfno-g-Mh1PlioTBMPTTX8IUDKTu1kf23Niuu-8wi44GChklcb0k8OOhuOjs0E_n-tsF9RM0Umb6khL9Zn2gUuWt9imp6vaJjOVLIfzEtG6AdErgLfxZ8EP_Vp81-97FUfwrXXTr2b1TxO29ME6-j_WlVA-7svTFpvqdp9Va7XD5LT1XOgSxE3oVsONA99BeahlkWbAHMzZ2FXthi2H5qyLRJMuqRkuc_2O7DYddB-IBbcJdmdYjV5P2qy9_ZdMtJGKTVXndu0W2RkAUwOeupNcXV-PrNwH29VWLsM6d7pZo_mLm5VxzVYbutCGVaO0m-kz8tSYJTTReNolvbJ6To4nuq75-oRO2zS9xQk9ppO24vn6BZl3QUc7oKPLGvacUQQdVaCjXdDRWlIE3e9f1AAOFyDKaEoBSOYzpRZwL8nX8_F0eOGYHh6OAN1w6XjSz7EoZREMMlmEMvIkD2WQS-nzDE5RlIHrFSwuPJZlhSjQHwE6MI9y-MmVmbdHtqu6Kl8R6rqSSVGEOSjV3I_jnLMSr-WFCKIIJu-Tw-Y0b251qZabh-TbJ3v6oO2cyA1jUHNfP2r5G_KkhfJbsr28W5XvyNaiWB0YPByASTb8_AfZSIg6 |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Springer Nature |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+sensitivity+to+Arg+side+chain+modification+of+IL-1%CE%B2+binding+to+type+I+and+type+II+receptors&rft.jtitle=Agents+and+Actions&rft.au=T%C3%B6m%C3%B6sk%C3%B6zi%2C+Zs&rft.au=Bugovics%2C+Gy&rft.au=Koncz%2C+S.&rft.au=Ar%C3%A1nyi%2C+P.&rft.date=1994-03-01&rft.issn=0065-4299&rft.eissn=1420-908X&rft.volume=41&rft.issue=1-2&rft.spage=105&rft.epage=107&rft_id=info:doi/10.1007%2FBF01986407&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_BF01986407 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0065-4299&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0065-4299&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0065-4299&client=summon |